Replies to post #202855 on Biotech Values

[mcbio]

TKAI -70% on termination of CRPC phase-3 for futility

This one always seemed too good to be true (in terms of valuation relative to near-term market opportunity) so probably shouldn't be shocked it blew up. I'm thankful I never came close to taking the plunge in this one.